Fibromyalgia Musculoskeletal Diseases
Conditions
Interventions
The program duration was 20 weeks with two 50-minute sessions each week (with a 2 day interval between in order to avoid muscle fatigue). The patients were divided into four groups, two in a Standard
Sponsors
International University of Catalunya
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Female 2. Aged between 30 to 59 years 3. Have an accredited medical certificate with an established diagnosis of FM according to the American College of Rheumatology 4. Have a light to moderate degree of impairment due to FM (FIQ less than 70) 5. Capable of walking without aid
Exclusion criteria
Exclusion criteria: 1. Suffering from an unstable cardiovascular pathology or any other medical condition that impedes physical exercise 2. History of fractures of the upper or lower members during the last three months 3. Suffering from neuromuscular disease or ingestion of drugs which affect neuromuscular function 4. Presence of any serious or terminal illness, history of myocardial infarction during the last three months 5. In litigation with management for recognition of occupational disability
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Muscle pain, measured using the Fibromyalgia Impact Questionnaire (FIQ)., assessed at baseline and after 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Heart rate, measured by Heart Rate Monitor Polar RC3 2. Weight 3. Self-perceived pain, measured by the visual analog scale (VAS) used to measure the intensity of self-perceived pain by the patient. This instrument was also used to measure the intensity of perceived fatigue by the patient. 4. Respiratory and aerobic function, measured by the six minute walk test (6MW) 5. Depression, measured using the Hamilton depression scale (HAM-D) 6. Overall impact of fibromyalgia using the FIQ. All measured every two weeks for 20 weeks | — |
Countries
Spain
Contacts
Public ContactAlfonso Castillo-Rodriguez
Outcome results
None listed